ITCI — Intra-Cellular Therapies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Intra-Cellular Therapies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	657	412	592	498	1,001
Net Total Accounts Receivable
Net Total Receivables	10.8	20.2	75.2	114	167
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	691	467	738	668	1,307
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	26.3	22.6	16.7	14.6	14.9
Other Long Term Assets
Total Assets	717	490	755	728	1,367
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	36.9	53.4	83.2	124	206
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	60.5	72	98.7	137	218
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	657	418	656	591	1,148
Total Liabilities & Shareholders' Equity	717	490	755	728	1,367
Total Common Shares Outstanding